Relationship between adipocyte hypertrophy and metabolic disturbances.
Enlargement of fat cells is known to be a factor stimulating metabolic rates in adipose tissue and thus playing a role in the pathogenesis of certain metabolic disorders. Excessive adipose-cell hypertrophy of the same degree was observed in disturbances of carbohydrate (e.g. in subclinical or maturity onset diabetes) as well as of triglyceride metabolism, despite the fact that body weight in these patient groups was lower than in control subjects (with the exception of subclinical diabetics). Significant correlations between adipocyte volumes and serum triglyceride levels are in agreement with this conception. Similar characteristics of insulin concentrations measured during an oral glucose tolerance test and adipose-cell hypertrophy of the same degree may suggest a comparable influence on the development of carbohydrate intolerance and hypertriglyceridemia. Moreover, our investigations show an increasing of the prevalence of diabetes mellitus, hypertriglyceridemia and hypercholesterolemia up to a Broca Index of 1.2. This points to an extremely high metabolic risk even in people with slight overweight provided the adipocytes are significantly enlarged. Thus, adipocyte size appears to be a good parameter to characterize metabolic impairments.
D000273:Adipose Tissue / Q000473:pathology*; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D003920:Diabetes Mellitus / Q000503:physiopathology*; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D005951:Glucose Tolerance Test; D006801:Humans; D006937:Hypercholesterolemia / Q000503:physiopathology*; D006953:Hyperlipoproteinemia Type IV / Q000503:physiopathology*; D006984:Hypertrophy; D007328:Insulin / Q000097:blood; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood*
D001786:Blood Glucose; D007328:Insulin; D014280:Triglycerides